Pfizer SWOT Analysis 2022 ❤️

The SWOT Analysis for Pfizer examines strengths, weaknesses, and opportunities as well as threats. Pfizer is one of the world’s largest pharmaceutical and vaccine companies. 

Pfizer Swot’s strengths and weaknesses are internal, while the opportunities and risks that it faces are external.

Pfizer’s SWOT Analysis is a valid management tool that allows it to compare its business and performance with other companies in the industry.

Pfizer is the largest pharmaceutical company in the world. Pfizer, a Fortune 500 company, is based in New York. 

Pfizer manufactures vaccines and other medicines. Pfizer manufactures medicines for neurology, cardiology, oncology, and endocrinology. 

pfizer swot analysis

It was founded in 1849. Charles F. Erhart and Charles Pfizer are the founders. Pfizer was founded as a manufacturer and distributor of fine chemicals. 

The SWOT Analysis of Pfizer will show the external and internal factors that influence the company’s business.

Pfizer manufactures and distributes vaccines and drugs for a broad range of prescription products. They also satisfy a wide variety of specifications.

Pfizer has received many honors and awards. Pfizer also received an award for its supply of innovative generic drugs and medical products.

SWOT Analysis of Pfizer

We can gain a better understanding of the company’s weaknesses and strengths by analyzing its internal strategic strengths. 

The pharmaceutical company conducts business around the world, so it may be able to take advantage of global brand recognition and global presence. 

It will also help the industry to survive. Pfizer employees must consider both the opportunities and the threats in each company and area. 

Pfizer must come up with innovative strategies and new ideas to grow the business while protecting it from the competition. 

If the Swot Analysis is not completed, Pfizer won’t be able to develop and survive in the long term.

Strengths In The SWOT Analysis of Pfizer

The firm’s strengths are its capabilities and resources, which it can use to create, develop, and sustain a competitive advantage in the market.

❤️ Strong brand recognition Pfizer products are well-known in the Biotechnology and Drugs industry. This has allowed the company to charge more than its competitors in Biotechnology and Drugs.

❤️ Large geographic presence – Pfizer’s extensive dealer and associate network not only helps in delivering efficient service to customers but also in managing competitive challenges within the Biotechnology & Drugs sector.

❤️ Brands that cater to different segments of the Biotechnology and Drugs segment– Pfizer’s extensive product offerings have allowed it to penetrate different segments of the Biotechnology and Drugs segment. The company has been able to diversify its revenue streams.

❤️ Diverse Revenue Model Over the years, Pfizer has ventured into other businesses than the Healthcare sector. The company has been able to develop a diverse revenue stream that goes beyond the Healthcare sector and Biotechnology segment.

❤️ Market Leader Position Pfizer is a strong leader in the Biotechnology and Drugs market. This has allowed the company to quickly scale up new product successes.

❤️ First Mover Advantage in an increasingly competitive market. Pfizer’s market share in Biotechnology and Drugs is rapidly growing with the introduction of new products.

Weaknesses In The SWOT Analysis of Pfizer

What are the “Weaknesses” in SWOT Analysis?

Pfizer’s weaknesses can be due to a lack of resources or strengths that the organization does not have. Leaders must be certain that the weakness is not due to poor strategic planning or a result of strategic choices.

❤️ Pfizer’s declining market share is offset by increasing revenues. The Biotechnology & Drugs sector is growing faster than Pfizer. Pfizer must analyze these trends and determine what it can do to ensure future growth.

❤️ Pfizer has low investments in its customer-oriented services. This could lead to competition gaining an advantage in the near future. Pfizer must increase its investment in research and development, especially in customer-oriented applications.

❤️ The decline in per-unit revenue for Pfizer is a sign that the industry’s competitiveness is putting pressure on profitability. This is how the company name can manage the situation. Objectively assess the present value propositions for the different products.

❤️ The high cost of replacing experts within Pfizer. Pfizer has few employees responsible for its knowledge base. It will be very difficult to replace them in current conditions.

❤️ Loyalty between suppliers is low. This is due to the history of Pfizer inventing new ways to lower prices in the supply chain.

❤️ The high turnover of employees at lower levels is also a concern for Pfizer. This can result in higher salaries for talent retention.

Opportunities In The SWOT Analysis of Pfizer

What are SWOT Analysis’s “Opportunities?”

Potential areas in which the firm can identify growth opportunities, profits, or market share are called opportunities.

❤️ Growing customer base in lower segments As customers move from unorganized operators to licensed players in the Healthcare sector. Pfizer will have the opportunity to enter the entry-level market by offering a low-cost, no-frills product.

❤️ Local Collaboration A tie-up with local players could also offer growth opportunities for Pfizer in the international market. Pfizer brings global execution and processes expertise to the table, while local players are able to draw on local expertise.

❤️ Rapid Expansion Of Economy The US economy is growing faster than any other developed country, which will give Pfizer the opportunity to expand in the US market. Pfizer already has the know-how necessary to compete in the US market.

❤️ Industrial productivity is being improved by rapid technological innovation and advancement. This allows suppliers to produce a wide range of products and services. This could allow Pfizer to expand into new products.

❤️ The increasing government regulations make it more difficult for unorganized players to participate in the Biotechnology and Drug industry. This could give Pfizer the opportunity to expand its customer base.

❤️ Potentials in Online Space Pfizer will be able to offer new services to customers in the Biotechnology and Drugs industry by increasing their adoption of online services.

 Threats In The SWOT Analysis of Pfizer

Threats refer to factors that could pose a threat to the firm’s business model due to changes in macroeconomic factors or changing consumer perceptions. You can manage threats but they cannot be controlled.

❤️ Growing distrust of institutions and increased threat of legal action for Pfizer – The WTO regulations and laws can be difficult to enforce in different markets. The legal process has become lengthy and expensive. This can result in Pfizer investing less in emerging markets, which could lead to slower growth.

❤️ The changing demographic As baby boomers retire and the new generation struggles to replace them, this can lead to higher profits for Pfizer. This could lead to Pfizer making higher profits in the short term, but it will also reduce margins in the long term as younger people are less loyal to a brand and more open to experimentation.

❤️ A changing political environment can have an impact on Pfizer’s business in both the local and international markets. This could include a US-China trade war, Brexit affecting European Union, and general instability in the Middle East.

❤️ Competition pressures As new product launches are decreasing in the Healthcare sector. Pfizer is now under additional competition. Pfizer cannot respond quickly to the demands of niche markets where disruptors are focused due to its large customer base.

❤️ Commoditization in the Product Segment The greatest challenge for Pfizer, and other players in this industry, is the growing commoditization in the Healthcare industry.

❤️ Stabilization in rural markets is a persistent challenge for Pfizer in the Biotechnology and Drugs segment. The reason is that rural markets are slow to adopt products. Pfizer is also more expensive to reach rural customers due to the distances involved and the lack of infrastructure.

Limitations of SWOT Analysis for Pfizer

The SWOT analysis is a popular tool for strategic planning, but it does have some limitations.

  • Some capabilities or factors can be both a strength or a weakness of an organization. This is one of the main limitations of SWOT analysis. Changes in environmental regulations can pose a threat to a company, but can also present an opportunity for the company. If the company is able to develop products faster than its competitors, it could be a competitive advantage.
  • SWOT is not a way to gain a competitive advantage. It should not be a goal in and of itself.
  • This matrix is only intended to be a starting point for discussion about how strategies might be implemented. The matrix provided an evaluation window, but not an implementation plan. It was not based on the strategic competitiveness of Pfizer.
  • SWOT is a static analysis – an analysis of the status quo that includes few potential changes. The dynamics of a competitive landscape may change as circumstances, capabilities, threats, and strategies change.
  • The SWOT analysis could lead a firm to focus too much on one external or internal factor when formulating its strategies. SWOT analysis may not show the interrelationships between key internal and externe factors. This could be important when devising strategies.

Weighted SWOT Analysis of Pfizer

Due to the limitations of the SWOT matrix/SWOT analysis, corporate managers decided that each firm’s internal strengths and weaknesses should be given weightage. 

Organizations assess the impact of future events on company performance and the likelihood that they will occur.

This is a Weighted SWOT analysis. This is better than a simple SWOT analysis. With the Weighted SWOT Analysis, Pfizer managers can concentrate on the most important factors and ignore the rest. 

This solves the problem of organizations making too many lists, but not enough critical factors.

Recommendations

The SWOT Analysis shows that Pfizer brands should target emerging markets by offering innovative products at a low price or at a discounted price. 

To compete with the many new and more effective drugs being created by other countries, Pfizer must also develop innovative medications. 

The company must also address its legal issues. It will result in an increase in the company’s financial resources that can be sustained.

The key points to consider when writing a Pfizer SWOT Analysis

Identifying the skills that are necessary for survival in the Pfizer Biotechnology & Drugs Industry.

– As much as possible, isolate the strengths and weaknesses of Pfizer.

– What strategies can Pfizer use to diversify risks from weaknesses and threats from the macroenvironment?

– Give proper weightage to all factors that contribute to Pfizer’s topline and bottom-line growth.

– Is there anyone who is critical of the organization and can tip the balance in favor of strengths and weaknesses?

References

  • https://www.britannica.com/topic/Pfizer-Inc
  • https://www.reuters.com/companies/PFE
  • https://www.pfizer.com/
  • https://www.ryerson.ca/content/dam/accounting-finance/smif/research/FIN65-G4-Pfizer-Analysis.pdf
  • https://www.fool.com/investing/value/2010/08/12/pfizer-strengths-weaknesses-opportunities-threats.aspx
  • https://www.projects4mba.com/swot-analysis-of-pfizer/4977/
  • Pfizer Drugwatch
  • Pfizer Pharmawords
  • Pfizer Wikipedia
  • Company Reputation Ranking

Pfizer SWOT Analysis: Conclusion

Pfizer, the former number one company, has fallen to second in the global list of top ten pharmaceutical companies.

Roche will be in 2020. In the last year, Pfizer has suffered from costly patent expirations that have impacted its revenues. 

But, the company’s strong profit growth is a sign that its operations efficiencies have paid off.

The company’s success in the past year was also affected by its work in developing and manufacturing the COVID-19 vaccine. 

Pfizer’s rapid response to the pandemic was remarkable, despite having its fair share of production problems. 

Pfizer is the only company to have an FDA-approved vaccine. It remains to be seen if the vaccine’s efficacy will make a difference for Pfizer over the next year.

Take a look at other SWOT analysis examples if you’re interested in increasing your business knowledge and problem solving skills. 

Our SWOT analysis templates as well as our how-to guide will help you learn more about SWOT analysis.

Leave a Comment